Author

Sandrine Hayette

Centre National de la Recherche ScientifiqueORCID 0009-0005-1431-9148Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Bioinformatics· 1 Genomics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:differential expression· 2 Approach:statistical model· 2 Research Focus:benchmarking· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1 Approach:machine learning (classical)· 1 Research Focus:software / tool· 1

Frequent Co-Authors

Claire BardeliD· 2 shared Kaddour ChabaneiD· 2 shared Sarah HuetiD· 2 shared Sylvain MareschaliD· 2 shared Béatrice GrangeiD· 1 shared Camille LéonceiD· 1 shared Franck Emmanuel NicoliniiD· 1 shared Gilles SallesiD· 1 shared

Activity by Year

2020-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 40 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBioinformatics

Claire BardelORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

BioinformaticsbioRxivPreprintMar 10, 2025

Detecting aberrant splicing events in short-read RNA-seq with SAMI, an UMI-aware Nextflow pipeline

Sylvain Mareschal, Valentin Wucher, Sarah Huet…·Claire Bardel

SAMI detects aberrant splicing events in short-read RNA-seq by focusing on non-recurring events in low-dimension data using a UMI-aware pipeline.

DOI 10.1101/2025.03.10.642333

bulk RNA-seqstatistical model

𝕏 PostBluesky

GenomicsbioRxivPreprintSep 7, 2020

Performances of targeted RNA-sequencing for the analysis of fusion transcripts, gene mutation and expression in haematological malignancies.

Sandrine Hayette, Béatrice Grange, Maxime Vallée…·Pierre Sujobert

This study evaluates targeted RNA sequencing for detecting fusion transcripts, mutations, and expression in hematological malignancies, finding it effective for diagnosing leukemia subtypes and identifying most DNA mutations at the mRNA level.

DOI 10.1101/2020.09.07.285981

humanbulk RNA-seq

𝕏 PostBluesky